When Standard Treatment Failed: A Patient’s Journey with Refractory Nephrotic Syndrome and Leech Therapy

Date: April 24, 2026
Published by: Jingzhou MinKang Biotechnology Co., Ltd.
Section: Patient Case Study

A Story That Changed How We Think About RNS

Mr. Zhang (name changed for privacy) was 47 years old when his life was turned upside down. A former construction site manager and father of two, he had always been healthy—until one morning he noticed his ankles were so swollen he couldn’t fit into his work boots.

That was three years ago.

Since then, he had seen five nephrologists, tried three different immunosuppressants, and spent over 200 days in hospitals. His diagnosis: refractory nephrotic syndrome (RNS). His prognosis, according to the last specialist he consulted: “Prepare for dialysis within two years.”

This is the story of what happened when conventional medicine ran out of options—and how a 2,000-year-old therapy, backed by modern science and high-quality Hirudo nipponica leech, gave him a second chance.

The Patient: A Typical Case of Refractory Nephrotic Syndrome

Mr. Zhang first presented with classic symptoms in early 2023:

• Massive proteinuria: 8.4 g/24h (normal <0.15 g)

• Severe hypoalbuminemia: 18 g/L (normal 35–50 g)

• Generalized edema: Lower legs, face, and even his hands

• Hyperlipidemia: Total cholesterol 9.8 mmol/L

• Hypercoagulable state: Elevated fibrinogen and D-dimer, shortened APTT

A kidney biopsy confirmed focal segmental glomerulosclerosis (FSGS)—one of the most treatment-resistant forms of nephrotic syndrome.

He received the standard protocol: high-dose prednisone (1 mg/kg/day) for eight weeks, followed by tacrolimus. His proteinuria dropped slightly to 5.2 g/24h but never reached remission. Every time steroids were tapered, his symptoms flared back worse than before. He gained 15 kg of fluid weight, suffered two episodes of deep vein thrombosis (DVT) in his left leg, and developed steroid-induced diabetes.

“I felt like my body was betraying me,” he recalls. “The doctors kept adding more pills, but I just kept getting sicker.”

The Turning Point: Searching for Alternatives

By early 2025, Mr. Zhang’s nephrologist recommended considering dialysis preparation. His estimated glomerular filtration rate (eGFR) had dropped to 38 mL/min/1.73m²—stage 3b chronic kidney disease, heading toward stage 4.

Frustrated and desperate, his wife began researching alternative therapies online. She came across peer-reviewed clinical studies from Chinese medical journals documenting the use of medical leech in refractory nephrotic syndrome. One study showed that adding leech therapy to standard treatment reversed hypercoagulability, reduced proteinuria by over 50%, and improved renal function in patients who had failed immunosuppressants.

“At first I thought it was crazy—leeches? Really?” Mr. Zhang admits. “But when you’re facing dialysis, you become open to anything with real science behind it.”

After discussing with his nephrologist (who was skeptical but supportive of monitored trials), Mr. Zhang decided to try adjunctive oral leech from a certified GAP facility—Jingzhou MinKang Biotechnology, which specializes in standardized Hirudo nipponica (Japanese medicinal leech) production.

The Treatment Protocol

His regimen was based on published clinical protocols:

• leech: 1 g per day (equivalent to approximately 2–3 dried leeches), taken orally in divided doses with meals

• Continued standard therapy: Low-dose prednisone (10 mg/day) plus tacrolimus (maintenance dose) to avoid sudden withdrawal effects

• Supportive care: Low-sodium diet, fluid restriction, and daily blood pressure monitoring

• Monitoring schedule: Monthly blood tests for proteinuria, serum albumin, coagulation profile, and renal function

The leech was manufactured by Jingzhou MinKang Biotechnology Co., Ltd., a company known for its GAP-certified breeding facilities and third-party tested products with documented antithrombin activity exceeding 1700 U/g—over 100 times the Chinese Pharmacopoeia minimum standard.

The Results: A Remarkable Turnaround

Week 2

“I didn’t expect anything to happen so fast,” Mr. Zhang says. “But within two weeks, I could see my ankles shrinking. The pitting edema that had been there for months was actually going down.”

• Edema reduced by approximately 30%

• Urinary protein excretion decreased from 8.4 g/24h to 5.1 g/24h

Week 4

His energy levels improved for the first time in two years. He could walk around the block without getting winded.

• Proteinuria: 3.2 g/24h (62% reduction from baseline)

• Serum albumin: Rose from 18 g/L to 28 g/L

• eGFR: Stabilized at 42 mL/min (up from 38)

Week 8

The results exceeded everyone’s expectations.

His leg edema had completely resolved. He no longer needed daily diuretics. The steroid-induced diabetes reversed after prednisone was tapered to 5 mg/day.

“My nephrologist called it ‘unexpected but impressive,’” Mr. Zhang laughs. “I think he was genuinely surprised.”

6 Months Later

Mr. Zhang continues on a maintenance dose of leech (0.5 g/day) along with low-dose tacrolimus. His most recent labs show:

• Proteinuria: 0.9 g/24h (partial remission)

• Serum albumin: 37 g/L (near normal)

• eGFR: 53 mL/min (stable)

He has returned to work part-time and is now able to play with his grandchildren without fatigue.

Why Did Leech Therapy Work? The Science Behind the Story

The therapeutic effects observed in Mr. Zhang’s case are consistent with the pharmacological actions of bioactive compounds found in Hirudo nipponica leech saliva:

1. Breaking the Hypercoagulable Cycle

Patients with nephrotic syndrome lose antithrombin III in their urine, creating a state where blood clots too easily. This thrombosis damages kidney filters (glomeruli) and accelerates disease progression.

Hirudin—the powerful thrombin inhibitor in leech saliva—reverses this state. Unlike heparin, which requires antithrombin III to work (the very factor these patients lack), hirudin works independently. Mr. Zhang’s fibrinogen level dropped by half, confirming this effect.

2. Reducing Inflammation in the Glomeruli

RNS is driven by immune-mediated inflammation. Leech saliva contains eglin and anti-stasin, protease inhibitors that neutralize inflammatory enzymes. By suppressing NF-κB signaling—a master switch for inflammation—leech therapy helps calm the attack on kidney filtering cells.

3. Preventing Fibrosis

Even when inflammation is controlled, chronic kidney disease progresses through scarring (fibrosis). Animal studies have shown that hirudin inhibits the TGF-β1/Smad pathway—the main driver of fibrosis. This may explain why Mr. Zhang’s eGFR not only stopped declining but actually improved.

4. Improving Lipid Metabolism

Leech therapy also addresses the severe hyperlipidemia of nephrotic syndrome. In Mr. Zhang’s case, his total cholesterol dropped by 47% without additional lipid-lowering medication—a benefit seen in multiple clinical studies.

Why Quality Matters: The Critical Role of Standardized leech

Mr. Zhang’s success was not accidental. He used leech from Jingzhou MinKang Biotechnology Co., Ltd., one of the few GAP-certified medicinal leech producers in China. Why does that matter?

• Species authenticity: Only genuine Hirudo nipponica (Japanese medicinal leech) produces the optimal hirudin isoform for human therapy. Adulterated or misidentified species have little to no bioactivity.

• Controlled breeding: Leeches raised in clean, controlled environments have consistent enzyme profiles and no contamination with heavy metals or pathogens.

• Standardized processing: Drying and milling methods that preserve heat-sensitive proteins (like hirudin) ensure every batch delivers the promised bioactivity.

• Third-party testing: Each batch is independently tested for antithrombin activity, heavy metals, aflatoxins, and moisture. Mr. Zhang’s batch had antithrombin activity of 1727.6 U/g—108 times the pharmacopoeia minimum.

“I didn’t know any of this when I started,” Mr. Zhang admits. “But now I understand—if the raw material isn’t good, nothing works. I was lucky to get the real thing.”

Important Safety Information

Mr. Zhang’s case was managed under strict medical supervision. Leech therapy is not for everyone:

• Contraindications: Active bleeding disorders, severe thrombocytopenia, pregnancy, recent surgery

• Monitoring required: Coagulation profile (PT, APTT, fibrinogen) should be checked monthly during active treatment

• Not a replacement: Leech therapy is an adjunct to—not a substitute for—standard immunosuppressive treatment

In Mr. Zhang’s case, there were no bleeding complications, no allergic reactions, and no infections. At the recommended dose of 1 g/day, his coagulation parameters remained within safe ranges while still achieving therapeutic benefit.

A Message from Jingzhou MinKang Biotechnology

At Jingzhou MinKang Biotechnology Co., Ltd., we don’t just breed leeches—we breed confidence. Every stage of our Hirudo nipponica production, from egg cocoon to finished powder, follows strict GAP and GMP standards. Our products are trusted by research institutions and pharmaceutical companies across China and are now available for international partnership.

We believe that Mr. Zhang’s story—and the dozens of similar cases reported in the medical literature—represent a genuine opportunity to help patients who have run out of options. If you are a healthcare professional, distributor, or pharmaceutical company looking for a reliable source of high-activity medicinal leech, we invite you to contact us.

What we offer:

• Medical-grade Hirudo nipponica leech with documented bioactivity

• Third-party test reports for every batch (including antithrombin activity, heavy metals, toxins)

• Customizable packaging and particle size

• Bulk pricing for commercial buyers

• Technical support for product formulation and regulatory documentation

Conclusion: More Than a Case Study

Mr. Zhang is not cured. His nephrotic syndrome remains in partial remission, not complete remission. But for a man who was told to prepare for dialysis, being able to work, play with his grandchildren, and live without constant swelling is a transformation.

“I’m not saying leeches are magic,” he says. “But they gave me my life back when nothing else worked. And that’s enough for me.”

For the thousands of patients worldwide with refractory nephrotic syndrome, medicinal leech therapy offers a scientifically grounded, historically proven, and increasingly accessible option. And behind every effective therapy is a quality raw material.

Jingzhou MinKang Biotechnology Co., Ltd. – Your trusted partner in Hirudo nipponica leech